Table 4 Medication-related characteristics of hypertensive patients on follow-up at ambulatory clinics of public health facilities in Bishoftu town, Ethiopia, 2022 (n = 398)
Variable | Category | Frequency | Percent |
|---|---|---|---|
Source of medication | By sponsorship | 83 | 20.9 |
Free of charge | 191 | 48 | |
Self-sponsored | 124 | 31.1 | |
Duration of therapy (years) |  < 5 | 142 | 35.7 |
5–10 | 147 | 36.9 | |
 > 10 | 109 | 27.4 | |
Side effect | Yes | 130 | 32.7 |
No | 268 | 67.3 | |
Experienced side effects (n = 130) | Dry mouth | 27 | 20.8 |
Erectile dysfunction | 16 | 12.3 | |
Headache | 27 | 20.8 | |
Weakness | 59 | 45.4 | |
Other* | 1 | 0.7 | |
Class of drugs | ACE inhibitors | 95 | 23.9 |
Calcium channel blockers | 127 | 31.9 | |
Thiazide diuretics | 146 | 36.7 | |
Beta-blockers | 30 | 7.5 | |
Number of medications | Monotherapy | 286 | 71.9 |
Drug combination | 112 | 28.1 | |
Medication adherence | Adherent | 175 | 44 |
Non-adherent | 223 | 56 |